RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS

3, 4 Methylenedioxymethamphetamine (MDMA) also known as Ecstasy is a common recreational drug of abuse and reports of abuse of tricyclic antidepressants are also known. We report two cases of misuse of selective serotonin re-uptake inhibitors (SSRIs) antidepressants in combination with Ecstasy and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, A.N., Catalan, J.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2000
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957712/
https://www.ncbi.nlm.nih.gov/pubmed/21407935
_version_ 1782188255701106688
author Singh, A.N.
Catalan, J.
author_facet Singh, A.N.
Catalan, J.
author_sort Singh, A.N.
collection PubMed
description 3, 4 Methylenedioxymethamphetamine (MDMA) also known as Ecstasy is a common recreational drug of abuse and reports of abuse of tricyclic antidepressants are also known. We report two cases of misuse of selective serotonin re-uptake inhibitors (SSRIs) antidepressants in combination with Ecstasy and their beneficial subjective effects experienced by misusers. We hypothesise the probable underlying pharmacological reasons and recommend its use in the treatment of neurotoxic effects of MDMA.
format Text
id pubmed-2957712
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29577122011-03-15 RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS Singh, A.N. Catalan, J. Indian J Psychiatry Case Report 3, 4 Methylenedioxymethamphetamine (MDMA) also known as Ecstasy is a common recreational drug of abuse and reports of abuse of tricyclic antidepressants are also known. We report two cases of misuse of selective serotonin re-uptake inhibitors (SSRIs) antidepressants in combination with Ecstasy and their beneficial subjective effects experienced by misusers. We hypothesise the probable underlying pharmacological reasons and recommend its use in the treatment of neurotoxic effects of MDMA. Medknow Publications 2000 /pmc/articles/PMC2957712/ /pubmed/21407935 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Singh, A.N.
Catalan, J.
RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
title RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
title_full RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
title_fullStr RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
title_full_unstemmed RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
title_short RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
title_sort rave drug (ecstasy) and selective serotonin reuptake inhibitor anti-depressants
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957712/
https://www.ncbi.nlm.nih.gov/pubmed/21407935
work_keys_str_mv AT singhan ravedrugecstasyandselectiveserotoninreuptakeinhibitorantidepressants
AT catalanj ravedrugecstasyandselectiveserotoninreuptakeinhibitorantidepressants

Ejemplares similares